Skip to main content

Table 2 Comparisons of fatty acid composition (mg/g of subcutaneous fat) and carcass parameters among commercial types

From: Distinct correlations between lipogenic gene expression and fatty acid composition of subcutaneous fat among cattle breeds

  Commercial type  
Salers Pirenaica Pirenaica Holstein-Friesian  
bulls (n = 13) bulls (n = 37) heifers (n = 29) cows (n = 21) p-value
Conformation 8.45 ± 0.37b 10.9 ± 0.3a 11.0 ± 0.3a 2.02 ± 0.64c < 0.001
Fatness 5.79 ± 0.46b 4.52 ± 0.33c 7.47 ± 0.33a 1.96 ± 0.81d < 0.001
 14:0 s1 31.6 ± 2.4ab 30.5 ± 1.7b 35.6 ± 1.8a 16.0 ± 4.2c < 0.001
 15:0 s2 4.71 ± 0.33 4.07 ± 0.23 3.99 ± 0.24 3.13 ± 0.57 0.111
 16:0 s3 230 ± 11ab 217 ± 8b 246 ± 8a 170 ± 20bc 0.002
 17:0 s4 9.01 ± 0.71 7.48 ± 0.50 8.08 ± 0.51 5.54 ± 1.22 0.057
 18:0 s5 131 ± 11 119 ± 8 98.0 ± 8.4 129 ± 20 0.059
 19:0 s6 0.565 ± 0.074a 0.595 ± 0.052a 0.38 ± 0.05b 0.708 ± 0.129a 0.005
 20:0 s7 0.907 ± 0.119ab 0.816 ± 0.084b 0.468 ± 0.085c 1.34 ± 0.21a < 0.001
 9c-14:1 p1 8.05 ± 1.27b 7.80 ± 0.90b 12.4 ± 0.9a 1.46 ± 2.21c < 0.001
 9c-15:1 p2 0.208 ± 0.028 0.183 ± 0.020 0.206 ± 0.020 0.15 ± 0.05 0.572
 9c-16:1 p3 36.7 ± 3.7b 33.5 ± 2.6b 45.3 ± 2.7a 9.74 ± 6.51c < 0.001
 9c-17:1 p4 6.73 ± 0.44a 5.24 ± 0.31b 6.96 ± 0.32a 2.15 ± 0.77c < 0.001
 9c-18:1 p5 308 ± 14a 261 ± 10b 333 ± 10a 196 ± 24c < 0.001
 9c-19:1 p6 0.987 ± 0.055a 0.789 ± 0.039b 0.801 ± 0.040b 0.795 ± 0.096ab 0.004
 9c-20:1 p7 0.726 ± 0.075 0.614 ± 0.053 0.728 ± 0.054 0.777 ± 0.130 0.231
 6-8 t-18:1 s8 3.14 ± 0.38bc 3.66 ± 0.27ab 4.12 ± 0.28a 1.83 ± 0.67c 0.010
 11 t-18:1 s9 10.3 ± 2.0 12.1 ± 1.4 8.20 ± 1.47 6.15 ± 3.55 0.162
 12 t-18:1 s10 2.26 ± 0.28 2.56 ± 0.20 2.71 ± 0.21 1.59 ± 0.50 0.174
 13 t/14 t-18:1 s11 4.37 ± 0.51b 5.23 ± 0.36ab 5.80 ± 0.37a 3.67 ± 0.89ab 0.029
 15c-18:1 s12 1.08 ± 0.16c 1.38 ± 0.11b 2.07 ± 0.11a 0.596 ± 0.271c < 0.001
 7 t,9c-18:2 p8 0.813 ± 0.116bc 0.845 ± 0.082b 1.25 ± 0.08a 0.295 ± 0.201c < 0.001
 9c,11 t-18:2 p9 3.11 ± 0.53 3.26 ± 0.376 3.53 ± 0.38 1.80 ± 0.92 0.453
 9c,12 t-18:2 p10 0.520 ± 0.067b 0.608 ± 0.048b 0.854 ± 0.048a 0.312 ± 0.118b < 0.001
 9c,13 t-18:2 p11 0.963 ± 0.131b 1.07 ± 0.09b 1.61 ± 0.09a 0.567 ± 0.229b < 0.001
 9c,15c-18:2 p12 0.461 ± 0.044b 0.341 ± 0.031c 0.587 ± 0.032a 0.266 ± 0.077bc < 0.001
 10 t,12c-18:2 i 0.221 ± 0.041b 0.195 ± 0.029b 0.324 ± 0.030a 0.099 ± 0.072b 0.001
 SFA 410 ± 21 382 ± 15 395 ± 15 328 ± 37 0.285
 MUFA 427 ± 18b 379 ± 13c 489 ± 13a 245 ± 32d < 0.001
  cis-MUFA 385 ± 18b 331 ± 13c 430 ± 13a 221 ± 32d < 0.001
  trans-MUFA 42.2 ± 5.2bc 48.3 ± 3.6b 58.9 ± 3.7a 23.5 ± 9.0c 0.001
 CLA 4.92 ± 0.56bc 5.22 ± 0.40b 6.42 ± 0.40a 2.68 ± 0.98c 0.002
 PUFA 29.9 ± 2.1a 24.3 ± 1.5bc 24.4 ± 1.5b 14.9 ± 3.7c 0.009
  n-6 27.7 ± 2.0a 22.2 ± 1.4b 22.1 ± 1.4b 12.8 ± 3.4c 0.005
  n-3 2.09 ± 0.19 2.05 ± 0.14 2.15 ± 0.14 2.04 ± 0.33 0.942
  1. Least square means ± standard deviations
  2. t trans, c cis, SFA saturated fatty acids, MUFA monounsaturated fatty acids, CLA conjugated linoleic acid, PUFA polyunsaturated fatty acids
  3. s substrate; p product; 1-12Same superscript numbers indicate the substrate-product pairs
  4. i inhibitor of SCD enzyme [25]
  5. a,b,c,d Values within a row with different superscripts differ significantly at P < 0.05
  6. SFA = 10:0 + 12:0 + 13:0 + 14:0 + 15:0 + 16:0 + 17:0 + 18:0 + 19:0 + 20:0 + 21:0 + 22:0 + 23:0 + 24:0
  7. MUFA = 9c-14:1 + 9c-15:1 + 7c-16:1 + 9c-16:1 + 10c-16:1 + 11c-16:1 + 12c-16:1 + 13c-16:1 + 5c-17:1 + 7c-17:1 + 9c-17:1 + 9c-18:1 + 11c-18:1 + 12c-18:1 + 13c-18:1 + 14c-18:1 + 15c-18:1 + 16c-18:1 + 9c-19:1 + 11c-19:1 + 13c-19:1 + 9c-20:1 + 11c-20:1 + 6 t/7 t-16:1 + 8 t-16:1 + 9 t-16:1 + 10 t-16:1 + 11 t/12 t-16:1 + 4 t-18:1 + 5 t-18:1 + 6-8 t-18:1 + 9 t-18:1 + 10 t-18:1 + 11 t-18:1 + 12 t-18:1 + 13 t/14 t-18:1 + 15 t-18:1 + 16 t-18:1
  8. CLA = 9c,11 t-18:2 + 7 t,9c-18:2 + 8c,10 t-18:2 + 9 t,11c-18:2 + 11c,13 t-18:2 + 10 t,12c-18:2 + 11 t,13c-18:2 + other t,t-18:2
  9. PUFA = 18:2n-6 + 18:3n-6 + 20:2n-6 + 20:3n-6 + 20:4n-6 + 22:4n-6 + 18:3n-3 + 18:4n-3 + 20:5n-3 + 22:5n-3 + 22:6n-3 + 20:3n-9